Our results also show that deletion of ATGL specifically in beta cells is, by lowering insulin secretion response, able to protect against HFD-induced hyperinsulinaemia, insulin resistance and obesity, and also able to promote elevated EE by activating BAT, and lipolysis and fat oxidation in WAT. This evidence concerns the gene PNPLA2 and Insulin resistance.